Neuvotion, a Darien, Connecticut-based MedTech startup, raised $1 million in seed funding to commercialize neurostimulation devices for rehabilitation and physical therapy.
The funds provided by the Long Island Angel Network and the Good Shepherd Rehabilitation Network are in the form of equity investment.
The funding will allow Neuvotion to expand its team while starting clinical studies and apply for FDA clearance.
Round: Seed Round
Funding Month: October 2021
Lead Investors: Long Island Angel Network and the Good Shepherd Rehabilitation Network
Company Website: https://www.neuvotion-inc.com/
Software Category: Rehabilitation and physical therapy
About the Company: The startup was founded in 2019 to innovate in the development of neurostimulation products specifically designed to help patients undergoing rehabilitation and physical therapy. By using AI to improve the targeting of the neurostimulation, the devices developed by the startup could prove extremely beneficial for patients with impairments resulting from strokes, traumatic injury, or other conditions.